Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

@article{Chaturvedi2008IncidenceTF,
  title={Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.},
  author={Anil K. Chaturvedi and Eric A. Engels and William F. Anderson and Maura Gillison},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2008},
  volume={26 4},
  pages={
          612-9
        }
}
  • A. ChaturvediE. Engels M. Gillison
  • Published 1 February 2008
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
PURPOSE To investigate the impact of human papillomavirus (HPV) on the epidemiology of oral squamous cell carcinomas (OSCCs) in the United States, we assessed differences in patient characteristics, incidence, and survival between potentially HPV-related and HPV-unrelated OSCC sites. PATIENTS AND METHODS Data from nine Surveillance, Epidemiology, and End Results program registries (1973 to 2004) were used to classify OSCCs by anatomic site as potentially HPV-related (n = 17,625) or HPV… 

Figures and Tables from this paper

Trends in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma Incidence, Vermont 1999–2013

There was an increasing trend of HPV-related OPSCC, specifically in males, and there appears to be a decreasing trend of OSCC in Vermont from 1999 to 2013.

Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Increases in the population-level incidence and survival of oropharyngeal cancers in the United States since 1984 are caused by HPV infection, and if recent incidence trends continue, the annual number of HPV-positive oroph throat cancers is expected to surpass the annual numbers of cervical cancers by the year 2020.

Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes.

  • Li-Ang LeeChung-Guei Huang T. Yen
  • Medicine, Biology
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
  • 2013

Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States.

The incidence of OPSCC is increasing among elderly patients in the United States, likely driven by HPV-associated cancers, and improved overall and cause-specific survival over time were observed for both younger and elderly patients with OPSCC.

Trends in head and neck cancer incidence in Denmark, 1978–2007: Focus on human papillomavirus associated sites

The results suggest a marked impact of HPV infection on the epidemiology of HNCs in Denmark and that the recent introduction of vaccination against HPV may in the future prevent HPV‐associated cancers of the head and neck.

Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas

The effect of sex on OS in OC and OP SCC appears to vary based on tumor location and HPV status, and this may be related to an emerging difference in the biology of HPV carcinogenesis in these locations.

Human papillomavirus in HNSCC: a European epidemiologic perspective.

Evolving disparities in the epidemiology of oral cavity and oropharyngeal cancers

The findings indicate that much of the HPVa rate increases were driven by rate increases among males and that there were changing differences in risk between genders, race, and geographic location.
...

References

SHOWING 1-10 OF 39 REFERENCES

Human Papillomavirus Infection and Survival in Oral Squamous Cell Cancer: A Population-Based Study

The presence of HPV type 16 DNA is independently associated with a favorable prognosis in patients with oral squamous cell carcinoma and may provide important prognostic information.

Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx

HP status was identified as an independent prognostic factor in oral and oropharyngeal cancers and appeared to be gender‐specific, suggesting the need for further study of the interaction between HPV and gender on survival.

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

  • P. WeinbergerZiwei Yu A. Psyrri
  • Medicine, Biology
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
A novel classification scheme that may have value for patient stratification for clinical trials testing HPV-targeted therapies is defined, namely HPV+/p16 high (class III) in oropharyngeal squamous cell carcinoma.

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

It is suggested that HPV-positive oropharyngeal cancers comprise a distinct molecular, clinical, and pathologic disease entity that is likely causally associated with HPV infection and that has a markedly improved prognosis.

Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence.

Based on the epidemiological evidence to date, it is reasonable to hypothesize that HPV-positive and -negative HNSCC represent different lineages formed through diverse, though overlapping, mechanisms of multistage tumorigenesis.

Case-control study of human papillomavirus and oropharyngeal cancer.

Oropharyngeal cancer was significantly associated with oral HPV type 16 (HPV-16) infection, and the degree of association increased with the number of vaginal-sex and oral-sex partners, among subjects with or without the established risk factors of tobacco and alcohol use.

Clinical implications of human papillomavirus in head and neck cancers.

  • C. FakhryM. Gillison
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
There is sufficient evidence to conclude that a diagnosis of HPV-positive HNSCC has significant prognostic implications; these patients have at least half the risk of death from H NSCC when compared with the HPV-negative patient.

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.

Prophylactic and therapeutic vaccines targeted against the viral capsid components and oncoproteins will provide the ultimate evidence for a role for HPV in HNSCC, if demonstrated to be effective in the prevention or therapy of this disease.

Changing patterns of tonsillar squamous cell carcinoma in the United States

Incidence rates of tonsillar SCC vary considerably by sex, race and time in a way that cannot be explained by changes in tonsillectomy practices alone and changes in environmental risk factors, including changes in smoking patterns and an increase in oral human papillomavirus infections.

Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus.

HPV type 16, which is present in most HPV-associated tonsillar cancers, was the most prevalent high-risk oral HPV infection.